Osteitis Deformans clinical trials
The registry lists 21 studies for Osteitis Deformans across more than 10 countries. 1 are recruiting or about to start. 12 of them are mainly about Osteitis Deformans (how this is decided). Per ClinicalTrials.gov, last updated 2026-07-01.
Get an email when these change. Save the Osteitis Deformans studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Novartis Pharmaceuticals (8) · University of California, Irvine (2) · Assistance Publique - Hôpitaux de Paris (1) · Emory University (1) · Sheba Medical Center (1) · State University of New York - Upstate Medical University (1) · Indiana University School of Medicine (1) · Organon and Co (1)
What is being tested here
Drugs under test in Osteitis Deformans studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Zoledronic Acid | 0 | 2 | 5 |
| Alendronate | 0 | 1 | 2 |
| Lapatinib | 0 | 1 | 2 |
| Ribociclib | 0 | 1 | 1 |
| Trastuzumab | 0 | 1 | 1 |
| Pamidronate | 0 | 0 | 1 |
| Calcium | 0 | 0 | 1 |
| Vitamin D | 0 | 0 | 1 |
Who these studies take
Of the 1 Osteitis Deformans studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (100%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 21 studies, recruiting or not: 10% stop at 75 or younger and 5% at 65; 33% take children; 14% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 21 of 21. search them.
- Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)RecruitingNCT013534301 country
- Genetic Analysis to Predict the Development of Paget's DiseaseActive, not recruitingNCT053099541 country
- Pathophysiology of Paget's Disease of BoneCompletedNCT028023841 country
- A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)CompletedNCT00480662Phase 3
- Optical Biopsy of Human Skin in Conjunction With Laser TreatmentCompletedNCT005405661 country
- Lapatinib and Bevacizumab for Metastatic Breast CancerCompletedNCT00444535Phase 21 country
- Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast CancerCompletedNCT03096847Phase 31 country
- Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) StudyCompletedNCT00553358Phase 324 countries
- Re-treatment of Participants With Paget's Disease Using Zoledronic AcidCompletedNCT00740129Phase 46 countries
- Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -CompletedNCT021064551 country
- Bisphosphonate Therapy for Osteogenesis ImperfectaCompletedNCT00159419Phase 4
- Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing SarcomaTerminatedNCT01882231Not applicable1 country
- Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)CompletedNCT00774020Phase 41 country
- Videoscopic Versus Open Inguinal Lymphadenectomy for CancerCompletedNCT01526486Not applicable1 country
- Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®CompletedNCT00668200Phase 41 country
- Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:TerminatedNCT006156281 country
- Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation PeriodCompletedNCT00103740Phase 310 countries
- Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation PeriodCompletedNCT00051636Phase 36 countries
- Genetic Study of Families Affected by Paget's Disease of BoneCompletedNCT007479941 country
- Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone DisordersStatus unknownNCT004035981 country
- 18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of BoneCompletedNCT00306046Not applicable1 country